I-MAB (FRA:0VY) Transcripts
I-Mab at Jefferies London Healthcare Conference Transcript
Nov 14, 2023
Half Year 2023 I-Mab Earnings Call Transcript
Aug 17, 2023
€2.14
(-0.93%)
Earnings
Full Year 2022 I-Mab Earnings Call Transcript
Mar 31, 2023
€3.2
(+3.90%)
Earnings
I-Mab Phase 2 Clinical Data of CD47 Antibody Lemzoparlimab Call Transcript
Sep 12, 2022
Half Year 2022 I-Mab Earnings Call Transcript
Aug 30, 2022
€5.8
(-2.52%)
Earnings
I-Mab R&D Day Transcript
Jul 20, 2022
I-Mab TJD5 Phase 2 Clinical Trial Data Update Call Transcript
May 27, 2022
Full Year 2021 I-Mab Earnings Call Transcript
Mar 29, 2022
€15.3
(-4.97%)
Earnings
I-Mab at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2022
I-Mab Corporate Call Transcript
Dec 21, 2021
I-Mab Most Recent Clinical Data Update Conference Call -- English Session Transcript
Dec 14, 2021
I-Mab and Jumpcan To Announce its Strategic Commercial Partnership on Eftansomatropin Alfa - Special Call Transcript
Nov 10, 2021
Half Year 2021 I-Mab Earnings & Corporate Progress Update Conference Call Transcript
Aug 31, 2021
I-Mab to Discuss Phase 1 Data on Highly Differentiated CD73 Antibody Uliledlimab at ASCO 2021 Call Transcript
Jun 07, 2021
I-Mab at Jefferies Healthcare Conference (Virtual) Transcript
Jun 01, 2021
I-Mab Corporate Analyst Meeting Transcript
Apr 26, 2021
Full Year 2020 I-Mab Earnings Call Transcript
Mar 29, 2021
€39.4
(-1.50%)
Earnings
IMAB Lemzoparlimab Phase 1 Clinical Trial Data Update Conference Call Transcript
Nov 13, 2020
I-Mab SITC Data Conference Call Transcript
Nov 09, 2020
I-Mab Company Update Conference Call Transcript
Sep 04, 2020
Half Year 2020 I-Mab Earnings Call Transcript
Aug 31, 2020
€26.2
(+0.77%)
Earnings
I-Mab Update Conference Call Transcript
May 28, 2020
I-Mab at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
May 14, 2020
Full Year 2019 I-Mab Earnings Call Transcript
Mar 31, 2020
Earnings